Boothbay Fund Management’s Aldeyra Therapeutics ALDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-16,521
| Closed | -$164K | – | 1534 |
|
|
2023
Q1 | $164K | Buy |
16,521
+2,996
| +22% | +$29.8K | ﹤0.01% | 1560 |
|
|
2022
Q4 | $94.1K | Buy |
+13,525
| New | +$94.1K | ﹤0.01% | 1562 |
|
|
2022
Q3 | – | Sell |
-56,082
| Closed | -$224K | – | 1921 |
|
|
2022
Q2 | $224K | Buy |
56,082
+2,870
| +5% | +$11.5K | 0.01% | 1428 |
|
|
2022
Q1 | $237K | Buy |
+53,212
| New | +$237K | 0.01% | 1404 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 1658 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 1627 |
|
|
2021
Q1 | – | Sell |
-18,277
| Closed | -$125K | – | 1275 |
|
|
2020
Q4 | $125K | Buy |
+18,277
| New | +$125K | ﹤0.01% | 998 |
|
|
2020
Q3 | – | Sell |
-12,075
| Closed | -$50K | – | 895 |
|
|
2020
Q2 | $50K | Buy |
12,075
+575
| +5% | +$2.38K | ﹤0.01% | 788 |
|
|
2020
Q1 | $28K | Buy |
+11,500
| New | +$28K | ﹤0.01% | 708 |
|
|
2019
Q2 | – | Sell |
-136,800
| Closed | -$1.24M | – | 621 |
|
|
2019
Q1 | $1.24M | Buy |
136,800
+116,848
| +586% | +$1.05M | 0.12% | 140 |
|
|
2018
Q4 | $166K | Buy |
+19,952
| New | +$166K | 0.02% | 429 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 650 |
|